How should HIV patients lower lipid levels?
Brown
B R
BR
University of Mississippi School of Pharmacy, and Clinical Liaison, Mississippi HIV Rural Area Network, University of Mississippi Medical Center, USA.
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D003327:Coronary Disease / Q000517:prevention & control; D004358:Drug Therapy; D005260:Female; D015658:HIV Infections / Q000097:blood* / Q000150:complications; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic
D000960:Hypolipidemic Agents; D008055:Lipids